any peer reviewed article?
More
Directory - International publications about radioprotective properties of fullerenes contains:
1. Višnja BOGDANOVIĆ, Karmen STANKOV, Ivana IˇCEVIĆ, Dragan ŽIKI,Aleksandra NIKOLIĆ, Slavica ŠOLAJIĆ, Aleksandar DJORDJEVIĆ and Gordana BOGDANOVIĆ. FULLERENOL C60(OH)24 EFFECTS ON ANTIOXIDATIVE ENZYMES ACTIVITY IN IRRADIATED HUMAN ERYTHROLEUKEMIA CELL LINE. J. Radiat. Res., 49, (2008) 321–327
2. Aaron P Brown, Eun Joo Chung, Mary Ellen Urick, William P Shield, Anastasia L Sowers, Angela Thetford, Uma T Shankavaram, James B Mitchell and Deborah E Citrin. RESEARCH EVALUATION OF THE FULLERENE COMPOUND DF-1 AS A RADIATION PROTECTOR. Radiation Oncology, 2010, 9 p.
3. Borbala Daroczi, Gabor Kari, Mary Frances McAleer, Jeffrey C.Wolf, Ulrich Rodeck, and Adam P. Dicker. IN VIVO RADIOPROTECTION BY THE FULLERENE NANOPARTICLE DF-1 AS ASSESSED IN A ZEBRAFISH MODEL. Clin. Cancer. Res., 12(23) (2006) 7086-7091.
4. G Albarran, V.A. Basiuk, E.V. Basiuk, J.M. Saniger. STABILITY OF FULLERENE UNDER IRRADIATION. Advances in Space Research, 33 (2004) 72-75.
5. Sanja Trajkovi´c, Silva Dobri´c, Vesna Ja´cevi´c, Viktorija Dragojevi´c-Simi´c, Zoran Milovanovi´c, Aleksandar Dordevic´. TISSUE-PROTECTIVE EFFECTS OF FULLERENOL C60(OH)24 AND AMIFOSTINE IN IRRADIATED RATS. Colloids and Surfaces B: Biointerfaces, 58 (2007) 39–43.
6. Li Xiao, Hiroya Takada, Kentaro Maeda, Mari Haramoto, Nobuhiko Miwa. ANTIOXIDANT EFFECTS OF WATER-SOLUBLE FULLERENE DERIVATIVES AGAINST ULTRAVIOLET RAY OR PEROXYLIPID THROUGH THEIR ACTION OF SCAVENGING THE REACTIVE OXYGEN SPECIES IN HUMAN SKIN KERATINOCYTES. Biomedicine & Pharmacotherapy 59 (2005) 351–358.
7. Loren K Mell & Benjamin Movsas. PHARMACOLOGIC NORMAL TISSUE PROTECTION IN CLINICAL RADIATION ONCOLOGY: FOCUS ON AMIFOSTINE. Drug Metab. Toxicol., 4(10) (2008) 1341-1350.
8. Q. Zhao, Y. Li, J. Xu, R Liu, W. Li. RADIOPROTECTION BY FULLERENOLS OF STYLONYCHIA MYTILUS EXPOSED TO γ-RAYS. J. Radial Biol., 2 (2005) 169-175.
Directory – Andrievsky G. and IPAC LLC publications about radioprotective properties of hydrated C60 fullerenes contains:
1. Grigory V. Andrievsky, Vadim I. Bruskov, Artem A. Tykhomyrov, Sergey V. Gudkov. PECULIARITIES OF THE ANTIOXIDANT AND RADIOPROTECTIVE EFFECTS OF HYDRATED C60 FULLERENE NANOSTUCTURES IN VITRO AND IN VIVO. Free Radical Biology & Medicine 47 (2009) 786–793.
2. G.V. Andrievsky, A.V. Zhmuro, L.V. Zabobonina. FIRST CLINICAL CASE OF TREATMENT OF PATIENT (VOLUNTEER) WITH RECTAL ADENOCARCINOMA BY HYDRATED C60 FULLERENES: NATURAL COURSE OF THE DISEASE OR NON-SPECIFIC ANTICANCER ACTIVITY? Message to the Symposium "Fullerenes in Biology and Medicine" of 197th Meeting of the American ECS (May 14-18, 2000, Toronto, Ontario, Canada). Abs# 700 (2 p.).
3. Analytical report IPAC LLC about C60HyFn non-toxicity (Russ), 25.02.2010, Kharkov, Ukraine, 2010, 12 p.(
http://www.ipacom.co...alytical_ru.pdf).
4. IS FULLERENE TOXICITY A MYTH? NANOWERK Research and General News, August 15, 2007 (
http://www.nanowerk....ewsid=2373.php# ).
5. OFFICIAL REPORTS ABOUT PRECLINICAL, CLINICAL TRIALS AND TESTING ON RADIOPROTECTIVE, NON-GENOTIOXIC PROPERTIES OF WATER SOLUTION OF HYDRATED C60 FULLERENE (see on IPAC LLC site
http://www.ipacom.co...bout-c60hyfn/70) and pdf-file with “Some important results from pre- and clinical trials of hydrated C60 fullerene”(
http://www.ipacom.co...trials_en.pdf).